Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis
Glatopa®（醋酸格拉替雷）的研发：首个获得FDA批准的用于治疗复发型多发性硬化症的仿制药疾病修饰疗法
期刊:
影响因子:
doi:10.1177/0897190017725984
Bell, Christine; Anderson, James; Ganguly, Tanmoy; Prescott, James; Capila, Ishan; Lansing, Jonathan C; Sachleben, Richard; Iyer, Mani; Fier, Ian; Roach, James; Storey, Kristina; Miller, Paul; Hall, Steven; Kantor, Daniel; Greenberg, Benjamin M; Nair, Kavita; Glajch, Joseph
